Reply  by Goldenberg, Ilan & Moss, Arthur J.
The recruitment of patients with remote myocardial infarction
and depressed left ventricular function without systematic coronary
artery status evaluation was precisely one of the limitations raised
by the MADIT-II study (6). Is it then appropriate to implement
the MADIT-II in patients considered for prophylactic ICD after
a coronary evaluation has been performed as warranted in clinical
practice in light of the present observations? Indeed, Goldenberg
et al. (1) observe that those patients who qualify for a revascular-
ization procedure subsequently performed will not enjoy a signif-
icant survival benefit due to the ICD. Similarly, for those whom a
revascularization procedure is not needed, hence without an
ischemic substrate, the corollary of the study suggests that their
risk of sudden death might be lower than expected and hence limit
the detectable benefit of ICD.
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Reply
We agree with the suggestion of Drs. Pascale and Fromer that a
coronary evaluation should be carried out in MADIT (Multicenter
Automatic Defibrillator Implantation Trial)-II–type patients with
a history of remote myocardial infarction (MI) and depressed left
ventricular dysfunction. This is also in agreement with current
guidelines for the management of patients with heart failure, in
which coronary angiography is recommended in patients who
present with angina or significant ischemia (Class I) and to eligible
asymptomatic heart failure patients with suspected coronary dis-
ease (Class IIa) (1). Our data, published in JACC, demonstrate that
coronary revascularization (CR) by either coronary artery bypass
graft surgery (CABG) or coronary angioplasty confers a significant
reduction in the risk of sudden cardiac death (SCD) in this
population (2). Furthermore, in the CABG-Patch trial (3) and in
the current MADIT-II subgroup analysis (2), no implantable
cardioverter-defibrillator (ICD) benefit was observed when the
device was implanted at the time of elective CABG or in the
immediate post-CR period.
Nevertheless, further studies are required to determine to what
extent complete CR provides a long-term protective effect against
SCD. In our analysis, the benefit conferred by CR was shown to
be time-dependent, and was no longer evident six months after the
revascularization procedure. Therefore, we continue to recommend
primary ICD therapy in MADIT-II type patients because it is
associated with a significant survival benefit in post-MI patients
with left ventricular dysfunction (4). Coronary evaluation should
be performed in eligible patients, and may be followed by complete
or partial revascularization. However, our data suggest that defi-
brillator implantation may be deferred for only a limited time-
period after CR in this high-risk population. In addition, Drs.
Pascale’s and Fromer’s suggestion, namely that benefit of the ICD
is limited in patients without an ischemic substrate, is not
supported by findings from recent primary intervention trials (5,6).
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